e-Profile Login and ID Quick Search
New Mexico News: Regulation Changes
Published in the December 2006 New Mexico Board of Pharmacy Newsletter
The August 28-29, 2006 New Mexico Board of Pharmacy meeting was a busy meeting. Five regulations were modified during this meeting. A brief summary of each regulation change is provided below. For a copy of the regulation, visit the Board Web site or contact the Board office.
Regulation change #1) 16.19.3 NMAC – Reciprocity was revised. This regulation change allows for the temporary licensure of pharmacists reciprocating to New Mexico. The reciprocating pharmacist must be in good standing in the state they are reciprocating from. The temporary license will be good for 60 days and is not renewable. During the 60 days, the reciprocating pharmacist can obtain permanent licensure. The fee for the temporary license is $50; this $50 will go towards the eventual licensing fee.
Regulation change #2) 16.19.12 NMAC – Fees was revised. The renewal fee for licensees currently serving in the United States Military in an active war zone or who serve in direct support of an operation in an active war zone is waived.
Regulation change #3) 16.19.20.31 NMAC – Controlled Substances/Pharmacy and Hospital Prescription and Dispensing Records was revised. In a pharmacy that complies with the Board’s Computerized Prescription Information regulation (16.19.6.22 NMAC), the name of the pharmacist filling a controlled substance prescription and the date the prescription was filled does not need to be placed on the prescription. This information will be available from the computer records. This includes all schedules.
Regulation change #4) 16.19.20.67 NMAC – Schedule III Controlled Substances was revised. This regulation contained a table of exempt anabolic steroid products. The table has been removed. The regulation now refers to the Code of Federal Regulations for controlled substances; §1308.34. Any federally exempt anabolic steroid product is also exempt by the Board.
Regulation change #5) 16.19.21 NMAC – Drug Precursors was revised. Wording was removed to correspond to the addition of pseudoephedrine-containing products added as a Schedule V controlled substance. The Board will no longer license distributors of pseudoephedrine-containing products.
